Terms: = Leukemia AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Treatment
119 results:
1. ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies.
Chervin AS; Stone JD; Konieczna I; Calabrese KM; Wang N; Haribhai D; Dong F; White MK; Rodriguez LE; Bukofzer GT; Ellis PA; Cosgrove C; Hecquet C; Clarin JD; Palma JP; Reilly EB
Mol Cancer Ther; 2023 Aug; 22(8):903-912. PubMed ID: 37294945
[TBL] [Abstract] [Full Text] [Related]
2. Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Closa L; Xicoy B; Zamora L; Estrada N; Colomer D; Herrero MJ; Vidal F; Alvarez-Larrán A; Caro JL
HLA; 2022 Feb; 99(2):93-104. PubMed ID: 34921518
[TBL] [Abstract] [Full Text] [Related]
3.
Jahantigh HR; Stufano A; Lovreglio P; Rezaee SA; Ahmadi K
J Biomol Struct Dyn; 2022 Sep; 40(15):6737-6754. PubMed ID: 33648421
[TBL] [Abstract] [Full Text] [Related]
4. Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach.
Hurtado López AM; Chen-Liang TH; Zurdo M; Carrillo-Tornel S; Panadero J; Salido EJ; Beltrán V; Muiña B; Amigo M; Navarro-Villamor N; Cifuentes R; Calabria I; Antón AI; Teruel R; Muro M; Vicente V; Jerez A
Oncoimmunology; 2020 Oct; 9(1):1824642. PubMed ID: 33101773
[TBL] [Abstract] [Full Text] [Related]
5.
Ureshino H; Shindo T; Tanaka H; Saji H; Kimura S
Mol Cancer Ther; 2021 Jan; 20(1):142-149. PubMed ID: 33082274
[TBL] [Abstract] [Full Text] [Related]
6. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
Front Immunol; 2020; 11():1804. PubMed ID: 32973756
[TBL] [Abstract] [Full Text] [Related]
7. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():659. PubMed ID: 32362897
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms of leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
Front Immunol; 2020; 11():147. PubMed ID: 32158444
[TBL] [Abstract] [Full Text] [Related]
9. Cancer testis antigen Cyclin A1 harbors several hla-a*02:01-restricted T cell epitopes, which are presented and recognized in vivo.
Teck AT; Urban S; Quass P; Nelde A; Schuster H; Letsch A; Busse A; Walz JS; Keilholz U; Ochsenreither S
Cancer Immunol Immunother; 2020 Jul; 69(7):1217-1227. PubMed ID: 32157447
[TBL] [Abstract] [Full Text] [Related]
10. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
[TBL] [Abstract] [Full Text] [Related]
11. Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I/II study.
Roex MCJ; van Balen P; Germeroth L; Hageman L; van Egmond E; Veld SAJ; Hoogstraten C; van Liempt E; Zwaginga JJ; de Wreede LC; Meij P; Vossen ACTM; Danhof S; Einsele H; Schaafsma MR; Veelken H; Halkes CJM; Jedema I; Falkenburg JHF
Leukemia; 2020 Mar; 34(3):831-844. PubMed ID: 31624377
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy.
Schillingmann DA; Riese SB; Vijayan V; Tischer-Zimmermann S; Schmetzer H; Maecker-Kolhoff B; Blasczyk R; Immenschuh S; Eiz-Vesper B
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678050
[TBL] [Abstract] [Full Text] [Related]
13. Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia.
van der Lee DI; Reijmers RM; Honders MW; Hagedoorn RS; de Jong RC; Kester MG; van der Steen DM; de Ru AH; Kweekel C; Bijen HM; Jedema I; Veelken H; van Veelen PA; Heemskerk MH; Falkenburg JHF; Griffioen M
J Clin Invest; 2019 Feb; 129(2):774-785. PubMed ID: 30640174
[TBL] [Abstract] [Full Text] [Related]
14. Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.
Akahori Y; Wang L; Yoneyama M; Seo N; Okumura S; Miyahara Y; Amaishi Y; Okamoto S; Mineno J; Ikeda H; Maki T; Fujiwara H; Akatsuka Y; Kato T; Shiku H
Blood; 2018 Sep; 132(11):1134-1145. PubMed ID: 30045840
[TBL] [Abstract] [Full Text] [Related]
15. Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.
Bertaina A; Andreani M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29470425
[TBL] [Abstract] [Full Text] [Related]
16. Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.
Tu X; Li S; Zhao L; Xiao R; Wang X; Zhu F
Virol Sin; 2017 Aug; 32(4):280-289. PubMed ID: 28840564
[TBL] [Abstract] [Full Text] [Related]
17. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
Chang AY; Dao T; Gejman RS; Jarvis CA; Scott A; Dubrovsky L; Mathias MD; Korontsvit T; Zakhaleva V; Curcio M; Hendrickson RC; Liu C; Scheinberg DA
J Clin Invest; 2017 Jun; 127(7):2705-2718. PubMed ID: 28628042
[TBL] [Abstract] [Full Text] [Related]
18. The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia.
Brunstein C; Zhang MJ; Barker J; St Martin A; Bashey A; de Lima M; Dehn J; Hematti P; Perales MA; Rocha V; Territo M; Weisdorf D; Eapen M
Haematologica; 2017 May; 102(5):941-947. PubMed ID: 28126967
[TBL] [Abstract] [Full Text] [Related]
19. Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.
Jahn L; van der Steen DM; Hagedoorn RS; Hombrink P; Kester MG; Schoonakker MP; de Ridder D; van Veelen PA; Falkenburg JH; Heemskerk MH
Oncotarget; 2016 Nov; 7(47):77021-77037. PubMed ID: 27776339
[TBL] [Abstract] [Full Text] [Related]
20. A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells.
Jaigirdar A; Rosenberg SA; Parkhurst M
J Immunother; 2016 Apr; 39(3):105-16. PubMed ID: 26938944
[TBL] [Abstract] [Full Text] [Related]
[Next]
